These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2386591)

  • 21. Utility of whole-blood aggregometry for evaluating anti-platelet therapy for Kawasaki disease.
    Suzuki C; Yahata T; Okamoto-Hamaoka A; Fujii M; Yoshioka A; Niwa Y; Ikeda K; Nakamura A; Hamaoka K
    Pediatr Int; 2013 Oct; 55(5):550-4. PubMed ID: 23659651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
    Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
    J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical Kawasaki disease: coronary aneurysms and thrombocytopenia.
    Kinney JB; Albano E; Krober MS; Stevenson JG
    South Med J; 1992 Jan; 85(1):40-2. PubMed ID: 1734535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean platelet volume in children with Kawasaki disease.
    Martínez-Ramírez R; Ríos-Solís J; Gallegos-Sauceda F; Sánchez C
    Minerva Pediatr (Torino); 2023 Apr; 75(2):320-321. PubMed ID: 37073581
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood platelet disorders and thrombotic tendencies associated with Kawasaki disease].
    Yamada K
    Nihon Rinsho; 1983 Sep; 41(9):2097-102. PubMed ID: 6663746
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased plasma adrenomedullin levels in Kawasaki disease with coronary artery involvement.
    Nishida K; Watanabe K; Echigo S; Mayumi M; Nishikimi T
    Am J Med; 2001 Aug; 111(2):165-6. PubMed ID: 11501552
    [No Abstract]   [Full Text] [Related]  

  • 27. [Plasma prostaglandin E2 and F2 alpha levels in patients with mucocutaneous lymph node syndrome (Kawasaki disease) and anaphylactoid purpura].
    Lee T
    Arerugi; 1985 Mar; 34(3):147-54. PubMed ID: 3862369
    [No Abstract]   [Full Text] [Related]  

  • 28. Incomplete Kawasaki disease: a pediatric diagnostic conflict.
    Celik U; Alhan E; Arabaci F
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):343-4. PubMed ID: 17785242
    [No Abstract]   [Full Text] [Related]  

  • 29. T-cell subsets in Kawasaki syndrome.
    Marchette NJ; Melish ME; Kihara S; Caplan F; Ching D
    Prog Clin Biol Res; 1987; 250():545-6. PubMed ID: 3501128
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biochemical and immunological laboratory findings in Kawasaki disease].
    Ogawa S
    Nihon Rinsho; 2008 Feb; 66(2):315-20. PubMed ID: 18260330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-classical Kawasaki disease in a 2 month old infant.
    Hartmann I; Weiss K; Bistritzer T; Baram S; Goldman M
    Isr Med Assoc J; 2006 Aug; 8(8):581-2. PubMed ID: 16958253
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased plasma endothelin levels in Kawasaki disease: a possible marker for Kawasaki disease.
    Morise T; Takeuchi Y; Takeda R; Karayalcin U; Yachie A; Miyawaki T
    Angiology; 1993 Sep; 44(9):719-23. PubMed ID: 8357099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peripheral blood monocyte/macrophages among mononuclear cells and serum tumor necrosis factor in patients with Kawasaki disease].
    Matsubara T
    Arerugi; 1988 Jul; 37(7):454-60. PubMed ID: 3214289
    [No Abstract]   [Full Text] [Related]  

  • 34. Kawasaki disease and the plight of the platelet.
    Corrigan JJ
    Am J Dis Child; 1986 Dec; 140(12):1223-4. PubMed ID: 3776936
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
    Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD
    Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukoerythroblastosis in Kawasaki disease.
    Sills RH; Cruz L
    Am J Pediatr Hematol Oncol; 1985; 7(2):193-6. PubMed ID: 3842564
    [No Abstract]   [Full Text] [Related]  

  • 37. Red blood cells as bioindicators of cardiovascular risk in Kawasaki disease: A case report.
    Pietraforte D; Gambardella L; Marchesi A; de Jacobis IT; Viora M; Del Principe D; Villani A; Malorni W; Straface E
    Int J Cardiol; 2015 Feb; 181():311-3. PubMed ID: 25540846
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome.
    Glode MP; Joffe LS; Wiggins J; Clarke SH; Hathaway WE
    J Pediatr; 1989 Sep; 115(3):469-73. PubMed ID: 2527976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome.
    Ueno K; Nomura Y; Hashiguchi T; Masuda K; Morita Y; Hazeki D; Eguchi T; Maruyama I; Kawano Y
    Br J Haematol; 2010 Jan; 148(2):285-92. PubMed ID: 19793253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS.
    Kawasaki T
    Acta Pathol Jpn; 1982; 32 Suppl 1():63-72. PubMed ID: 7187577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.